Six Months of Trastuzumab Effective in HER2+ Breast Cancer Six Months of Trastuzumab Effective in HER2+ Breast Cancer

A large-scale data analysis has confirmed that 6 months of trastuzumab is just as effective as 12 months in HER2+ early breast cancer, but the question is whether it will be adopted, say experts.Medscape News UK
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news